Welcome to the Canadian Longevity Association
Canada’s Premiere Longevity Advocacy Association
Visitor's Very First Impression
Write a Title That Grabs Them
This subtitle area is used to create a quick summary of what the site is about and garner interest in exploring it. Place primary keywords in the title and secondary keywords here.
Main Product or Service
What is your biggest seller or service? People want to find it fast so mention it here.
2nd Product or Service
Not your most popular but a product or service that provides value to a visitor. They might of come for the main product but this second one will give them an extra reason to stay.
3rd Product or Service
Finish the triple hit combo by engaging with people's natural curiosity. You want the average visitor to go "hmm what is this about?". Could be a product/ service/ blog article or the story of your business.
The CLA In Brief
The Canadian Longevity Association (CLA) is dedicated to pioneering advancements in the field of longevity research. Our mission is to position Canada as a central hub and critical player in the emerging global longevity industry. We are a federally incorporated nonprofit organisation dedicated to supporting individuals, organisations, and governments in Canada in efforts to extend the longevity and healthspan of Canadians.
Healthspan refers to the period of life during which an individual remains healthy, free from serious disease and disability. The importance of extending the healthspan lies in its potential to reduce the burden of age-related diseases like diabetes, heart disease, and dementia, thereby improving overall quality of life for individuals and reducing healthcare costs for society.
While the publicly funded Canadian healthcare system provides robust support for clear medical needs, many interventions to extend one’s longevity and healthspan are still outside the scope of the traditional medical system or too nascent to be integrated. Therefore, it is crucial to ensure that Canadian individuals who are keen to explore these advancements have access to them in Canada, allowing for their evaluation, testing, and potential wider adoption to benefit all Canadians.
Our mission includes:
Advocating for governmental support of longevity and healthspan initiatives.
Supporting individuals and organisations in Canada in efforts related to extending the longevity and healthspan of Canadians.
Celebrating Canadian contributions to the field of longevity and geroprotection.
Disseminating basic research related to geroprotection and finding on interventions related to longevity and healthspan.
Collaborating with international organisations who are involved in the promotion of in the science of longevity and healthspan extension.
Our mission is to responsibly advocate for access and support of interventions to improve the longevity and healthspan of Canadians, but we need your support. Joining as a member lets us build a community that aids us in our advocacy efforts. Together, we can promote a healthier, longer life for all Canadians.
Sustainable Longevity for All Canadians
The coming decades will usher in a medical revolution that will significantly enhance human health and longevity. Research advances are already creating breakthroughs that treat previously incurable diseases, and innovations in the science of aging promise to address age-related diseases and their corresponding decline. Extensive research findings have shown that this future is a near-certainty; however, the speed of its arrival depends on the actions we take today.
The Canadian Longevity Association stands at the forefront as Canada’s premiere organization advocating for enhanced longevity policies, disseminating cutting-edge research to the public, coordinating collaboration among researchers, partnering with global longevity organizations, and creating the necessary infrastructure from research to manufacturing and productization. Our mission is to accelerate treatments, increase healthy lifespans, improve outcomes, and make longevity treatments more affordable for all Canadians.
Canada is poised to lead this crucial research, not only for its humanitarian benefits but also due to the significant economic potential of this industry. By driving advancements in healthcare and longevity treatments, we aim to elevate Canada’s national stature and ensure we remain a global leader in disseminating advanced health technologies.
The CLA is the first and only national non-profit organization of its kind dedicated to realizing this unique vision. We unite research scientists, policymakers, medical practitioners, technologists, financing experts, administrative personnel, and more to forge a clear path in the fight against aging. Together, we are establishing a definitive roadmap to achieving better health for all Canadians.
Latest Updates From the CLA
(An automated feed of our social presence posts, e.g. the Instagram feed, feeds from LinkedIn, X, or any other platform go here)
Longevity News
(An automated feed goes of the latest news and research goes here)
- February 2025 Longevity Review
As we emerge from the depth of winter, this month we will take a look at how the combination of Omega 3, Vitamin D and resistance exercise can slow down the aging process; how young blood plasma can help with surgical outcomes in a human trial; how Klotho gene therapy can increase the lifespan of mice; and in the Canadian content study, how cellular reprogramming can protect retinal neurons and maintain vision in a mouse model of multiple sclerosis. In the Supplemental Section, you’ll find […]
- January 2025 Longevity Review
Kicking off the new year with a lifespan special, we will take a look at reversing the senescence of senescent cells to increase mouse lifespan; the discovery and beneficial effects of a subset of youthful stem cells which can also increase mouse longevity; the most comprehensive study of life-extending molecules in the roundworm c.elegans; and in the Canadian Content study, how disrupting the antioxidant defences in a specific organ in c.elegans can increase its lifespan. In the Supplemental […]
- December 2024 Longevity Review
Hello and welcome to the final longevity review of 2024. This month we will take a look at gene therapy to increase telomere length; freeing the immune system to remove senescent cells; using probiotics to help with sarcopenia; and, in the Canadian content study, employing extracellular vesicles to deliver drugs to the brain to combat neuroinflammation. In the Supplemental Section, you’ll find in Lifestyle how exercise and sleep improve memory the next day; in Diet, how moderate wine […]
- November 2024 Longevity Review
As we get closer to the holiday season, this review returns to its monthly format after a brief foray into a bi-monthly issue. Now that I have caught up with these reviews, we will take a look at how 16:8 time restricted eating in healthy, normal weight individuals can still reduce weight and fat mass, as well as improve the immune system and make their gut microbiome younger; how ergothioneine could improve cognition in older individuals with mild cognitive impairment; and for the first time, […]
- September & October 2024 Longevity Review Part 2
In a bid to finally catch up with these Longevity Reviews, I took the decision to combine the results for September and October. This led to a fair amount of hand wringing as I sought to include only the biggest and most important studies for those two months, but my final selection for the Highlights Sections sees us taking a look at the most comprehensive dietary restriction study in mice to date; how the rat lifespan record might have been broken with exosome treatment; how an inhibitor of […]
- Heat May Speed Up Epigenetic Aging in Older Adults
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer
- Anti-Amyloid Drug Reduces Alzheimer’s Risk in Small Subgroup
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s disease in a subgroup of participants
- Joshua “Scotch” McClure: “Infectious Disease Drives Aging”
Like many people, I’m both wary of and intrigued by people who make bombastic claims. Years in the longevity field have taught me caution but also that big claims are not necessarily
- Scientists Create Cytoskeleton-Like Structures From RNA
In a new study, researchers report producing self-assembling nanotubes and rings made from RNA molecules inside artificial cell-like lipid vesicles. In the future, this technology could
- A Core Senescence Biomarker Fights Inflammation
Researchers publishing in Nature Communications have found that p53, a biomarker and inducer of senescence, suppresses both inflammation and DNA damage
Support the CLA
Your support is critical in helping us achieve our mission, to advance longevity research, eradicate the diseases of aging, and promote healthy living. Every contribution, whether through donations, subscribing to our newsletter, or volunteering your time, makes a significant impact.